Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/18/15 → 06/17/18 |
Funding
- Astellas Pharma Global Development Incorporated: $147,595.87
CYP3A5 and 3A4 Haplotypes and Relation to Tacrolimus Pharmacokinetics and Adverse Effects: Influence of Race and Sex
- Tornatore-Morse, Kathleen (PI)
- Venuto, Rocco C (CoI)
Project: Research